Approvals/TGA/AVELOX IV 400 moxifloxacin 400 mg/250 mL (as hydrochloride) intravenous infusion solution bottle

Approved

STANDARD

AVELOX IV 400 moxifloxacin 400 mg/250 mL (as hydrochloride) intravenous infusion solution bottle

Bayer Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e620bc934cf70023
Product Name: AVELOX IV 400 moxifloxacin 400 mg/250 mL (as hydrochloride) intravenous infusion solution bottle
Artg Id: 81598
Artg Name: AVELOX IV 400 moxifloxacin 400 mg/250 mL (as hydrochloride) intravenous infusion solution bottle
Sponsor: Bayer Australia Ltd
Company Detail Path: /organization/bayer-australia-ltd
Artg Date: 2002-01-31
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/17ac531d446860d72d680836b3f1b5a5.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e746c3ebc8ba80ba8f5f6171d92aabc0.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

e620bc934cf70023

Type

Standard